|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500114704 |
|
最近更新日期: Date of Last Refreshed on: |
2025-12-16 17:17:59 |
|
注册时间: Date of Registration: |
2025-12-16 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
医护康一体化延续护理在膝关节前交叉韧带合并半月板损伤术后患者功能康复中的应用 |
|
Public title: |
Application of integrated medical and nursing continuity care in functional rehabilitation of patients after anterior cruciate ligament and meniscus injury surgery |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
医护康一体化延续护理在膝关节前交叉韧带合并半月板损伤术后患者功能康复中的应用 |
|
Scientific title: |
Application of integrated medical and nursing continuity care in functional rehabilitation of patients after anterior cruciate ligament and meniscus injury surgery |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
陈欢欢 |
研究负责人: |
陈欢欢 |
|
Applicant: |
Chen Huanhuan |
Study leader: |
Chen Huanhuan |
|
申请注册联系人电话: Applicant telephone: |
+86 137 8014 9899 |
研究负责人电话: Study leader's telephone: |
+86 137 8014 9899 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
543727747@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
543727747@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
中国浙江省温州市永嘉县东瓯街道林垟大厦A栋2301室 |
研究负责人通讯地址: |
中国浙江省温州市永嘉县东瓯街道林垟大厦A栋2301室 |
|
Applicant address: |
Room 2301, Building A, Linyang Building, Dong'ou Street, Yongjia County, Wenzhou City, Zhejiang Province, China |
Study leader's address: |
Room 2301, Building A, Linyang Building, Dong'ou Street, Yongjia County, Wenzhou City, Zhejiang Province, China |
|
申请注册联系人邮政编码: Applicant postcode: |
325000 |
研究负责人邮政编码: Study leader's postcode: |
325000 |
|
申请人所在单位: |
温州医科大学附属第二医院育英儿童医院 |
||
|
Applicant's institution: |
The Second A?liated Hospital and Yuying Children’s Hospital of Wenzhou Medical University |
||
|
研究负责人所在单位: |
温州医科大学附属第二医院育英儿童医院 |
||
|
Affiliation of the Leader: |
The Second A?liated Hospital and Yuying Children’s Hospital of Wenzhou Medical University |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
伦审(2025-K-338-02) |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
温州医科大学附属第二医院 温州医科大学附属育英儿童医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of the Second Affiliated Hospital of Wenzhou Medical University and Wenzhou Medical University Affiliated Yuying Children's Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-11-10 00:00:00 |
||
|
伦理委员会联系人: |
陈苑 |
||
|
Contact Name of the ethic committee: |
Chen Yuan |
||
|
伦理委员会联系地址: |
中国浙江省温州市龙湾区温州大道东段1111号 |
||
|
Contact Address of the ethic committee: |
No. 1111, East Section of Wenzhou Avenue, Longwan District, Wenzhou City, Zhejiang Province, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 137 5849 6849 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
温州医科大学附属第二医院育英儿童医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The Second A?liated Hospital and Yuying Children’s Hospital of Wenzhou Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
中国浙江省温州市学院西路109号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
109, Xueyuanxi road, Wenzhou,Zhejiang,China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹经费 |
||||||||||||||||||||||
|
Source(s) of funding: |
Self-funded |
||||||||||||||||||||||
|
Target disease: |
anterior cruciate ligament and meniscus injury |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
本研究针对接受膝关节前交叉韧带重建联合半月板修复术后患者,对不同延续护理模式的随访结果展开分析,进而构建出医护康一体化延续护理模式。该模式着重发挥护士的“桥梁”作用,充分拓展其职能的广度与深度,为术后患者在功能锻炼、切口照护、疼痛管理、饮食调控及高危并发症预防等方面,提供专业、全程且无缝衔接的延续护理服务。此举旨在填补患者出院后护理需求的“最后一公里”空白,切实满足患者需求,提高患者功能锻炼依从性,推动康复进程,提升患者满意度。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study focused on patients who underwent anterior cruciate ligament reconstruction combined with meniscus repair, analyzing the follow-up outcomes of different continuous care models, and subsequently establishing an integrated medical-nursing continuous care model. This model emphasizes the nurse's role as a 'bridge,' fully expanding the scope and depth of their functions to provide professional, comprehensive, and seamless continuous care services for postoperative patients in areas such as functional exercise, incision care, pain management, dietary regulation, and prevention of high-risk complications. The aim is to address the 'last mile' gap in care after patient discharge, effectively meet patient needs, improve compliance with functional exercises, promote the rehabilitation process, and enhance patient satisfaction. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.初次行单侧膝关节前交叉韧带重建合并半月板修复术,且均由本院运动医学科医师进行手术治疗者。 2.文化程度小学及以上且有网络和智能手机等设备,会使用微信者。 3.认知及表达能力正常者。 4.患者或家属知情同意并自愿参与本研究。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Patients undergoing their first unilateral anterior cruciate ligament reconstruction combined with meniscus repair, with all surgeries performed by sports medicine physicians at our hospital. 2. Individuals with at least a primary school education who have access to the internet and a smartphone, and are able to use WeChat. 3. Individuals with normal cognitive and expressive abilities. 4. Patients or their family members who have provided informed consent and voluntarily agree to participate in this study. |
||||||||||||||||||||||
|
排除标准: |
1.合并后交叉韧带损伤或合并血管及神经损伤者。 2.合并严重心、肺、肝、肾等系统疾病者。 3.随访脱落者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Those with combined cruciate ligament injuries or combined vascular and nerve injuries. 2. Those with severe diseases of the heart, lungs, liver, kidneys, or other systems. 3. Those lost to follow-up. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-12-19 00:00:00至 To 2026-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2025-12-19 00:00:00 至 To 2026-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
采用便利抽样的方法,按照出院顺序给与1—100数字编号,奇数者纳入干预组,偶数者纳入对照组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Using a convenience sampling method, numbers from 1 to 100 were assigned according to the discharge order, with odd numbers included in the intervention group and even numbers in the control group. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
对数据收集者、录入者及评估者实施盲法 |
|
Blinding: |
Implement blinding for data collectors, data entry personnel, and evaluators |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2025.12.16中国临床试验注册中心 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
December 16, 2025, Chinese Clinical Trial Registry |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例报告书及SPSS22.0软件 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Report Form and SPSS 22.0 Software |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |